课题基金 / 基金详情

ALPHA 1 ADRENERGIC RESPONSES IN SMOOTH MUSCLE

ALPHA 1 ADRENERGIC RESPONSES IN SMOOTH MUSCLE
平滑肌中的 ALPHA 1 肾上腺素反应
批准号:
6638279
负责人:
BRIAN B HOFFMAN
金额:
$22.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-01 至 2005-05-31

项目摘要

项目成果

BRIAN B HOFFMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The goals of this proposal relate to deepening understanding of the consequences of activation of alpha1 adrenergic receptors, with emphasis on signal transduction mechanisms in vascular smooth muscle cells. Preliminary data indicate that the contribution of alpha1 receptors to vascular cell growth has been underestimated in comparison to peptide growth factors. The proposal serves to continue exploration of biologically interesting alpha1 receptor mechanisms that could also have clinical significance for atherosclerosis and vascular growth in hypertension. The proposal has two major aims: 1 Signal transduction mechanisms of al receptors in vascular smooth muscle and transfected NIH3T3 cells. al receptors activate a variety of signaling pathways including MAP kinases, PI 3-kinase, and p70S6 kinase. These pathways have importance for receptor-activated increases in protein and DNA synthesis. The primary purpose of this aim is to develop deeper insight into the mechanisms used by alpha1 receptors to activate these signaling pathways and to contrast them with the actions of angiotensin II and other growth factors such as platelet derived growth factor. 1A. Investigate the mechanism for the essential role of Ca2+ in alpha1 receptor- mediated activation of MAP kinase and p70S6 kinase and tyrosine protein phosphorylation, especially of phospholipase Cgamma. 1B. Determine the role of alpha1 receptors in the activation of PI-3 kinase isoforms and p70S6 kinase. 1C. alpha1 and angiotensin II receptors stimulate PI 3-kinase activity in vascular smooth muscle cells yet do not stimulate PKB which is generally activated down-stream of PI 3-kinase. What is the mechanism responsible for this inability to activate PKB? 2. Regulation of gene expression by alpha1 receptors toys Preliminary results suggest that alpha1 receptors increase expression of a range of genes, including nerve growth factor and various tyrosine kinases and transcription factors. We propose to characterize using microarray gene chip technology the pattern of gene expression induced by alpha1 receptors in vascular smooth muscle and by specific alpha1 receptor subtypes in transfected HEK-293 cells. We will then characterize in detail the effects of alpha1 receptors on expression of identified genes of particular biological interest, both at the mRNA and protein level, as well as investigating possible biological implications of the change in expression of these proteins.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
Nuclear run-on assays for measurement of adrenergic receptor transcription rate.
用于测量肾上腺素受体转录率的核连续测定。
DOI: 10.1385/1-59259-684-3:169
发表时间: 2000
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Hu,ZW, Hoffman,BB]
通讯作者: Hoffman,BB
Prolonged activation of alpha 1 adrenoceptors induces down-regulation of protein kinase C in vascular smooth muscle.
α1 肾上腺素受体的长期激活会导致血管平滑肌中蛋白激酶 C 的下调。
DOI: 10.1097/00005344-199212000-00020
发表时间: 1992
期刊: Journal of cardiovascular pharmacology
影响因子: 3
作者: [Hu,Z, Azhar,S, Hoffman,BB]
通讯作者: Hoffman,BB
alpha1-adrenergic receptor activation of c-fos expression in transfected rat-1 fibroblasts: role of Ca2+.
转染的rat-1成纤维细胞中α1-肾上腺素受体激活c-fos表达:Ca2+的作用。
DOI: --
发表时间: 1999
期刊: The Journal of pharmacology and experimental therapeutics
影响因子: --
作者: [Chen,J, Lin,R, Hu,ZW, Hoffman,BB]
通讯作者: Hoffman,BB
Adaptive increase in adenylyl cyclase activity in NG108-15 and S49 cells induced by chronic treatment with inhibitory drugs is not due to a decrease in cyclic AMP concentrations.
抑制性药物长期治疗诱导的 NG108-15 和 S49 细胞中腺苷酸环化酶活性的适应性增加并不是由于环 AMP 浓度的降低。
DOI: 10.1016/0898-6568(92)90036-8
发表时间: 1992
期刊: Cellular signalling
影响因子: 4.8
作者: [Thomas,JM, Hoffman,BB]
通讯作者: Hoffman,BB
19
    Models of Diabetes and Arterial Dysfunction
    • 批准号:
      7524096
    • 项目类别:
    • 资助金额:
      $27.31万
    • 财政年份:
      2007
    • 负责人:
      BRIAN B HOFFMAN
    • 依托单位:
    Models of Diabetes and Arterial Dysfunction
    • 批准号:
      7524089
    • 项目类别:
    • 资助金额:
      $27.76万
    • 财政年份:
      2006
    • 负责人:
      BRIAN B HOFFMAN
    • 依托单位:
    Models of Diabetes and Arterial Dysfunction
    • 批准号:
      7029366
    • 项目类别:
    • 资助金额:
      $28.79万
    • 财政年份:
      2005
    • 负责人:
      BRIAN B HOFFMAN
    • 依托单位:
    MECHANISMS FOR TOLERANCE TO ACTIONS OF A2 AGONISTS
    • 批准号:
      6343020
    • 项目类别:
    • 资助金额:
      $26.29万
    • 财政年份:
      1999
    • 负责人:
      BRIAN B HOFFMAN
    • 依托单位:
    海外基金